Setting goals for drug policy: harm reduction or use reduction?

Area of Science:

• Public Health
• Policy Studies
• Substance Use Research

Background:

• United States drug policy traditionally prioritizes use reduction.
• Harm reduction presents a prominent alternative approach to drug policy.
• Both 'use reduction' and 'harm reduction' lack precise definitions, impacting policy clarity.

Purpose of the Study:

• To stimulate debate on the comparative effectiveness of use reduction and harm reduction strategies.
• To clarify the distinct objectives and implications of use reduction and harm reduction.
• To propose an overarching goal for drug policy that encompasses various stages of the drug lifecycle.

Main Methods:

• Conceptual analysis of drug policy goals and terminology.
• Evaluation of existing measures associated with use reduction and harm reduction.
• Examination of the influence of national goals on decentralized drug policy decision-making.

Main Results:

• Current measures for both use reduction and harm reduction goals are deemed inadequate.
• Harm reduction measures are considered even less effective than use reduction measures.
• National policy goals significantly shape individual policy choices and programmatic decisions.

Conclusions:

• Minimizing total harm from drug production, distribution, consumption, and control should be the primary objective of drug policy.
• Use reduction should be strategically employed as a primary method to achieve the goal of minimized overall harm.
• Clearer definitions and goals are essential for effective and transparent drug policy development.